CME Group Inc. (NASDAQ:CME) CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total transaction of $342,075.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

CME Group Inc. (NASDAQ CME) traded up 0.38% during trading on Thursday, reaching $137.71. 967,275 shares of the company were exchanged. The firm’s 50 day moving average price is $131.65 and its 200-day moving average price is $123.63. The stock has a market capitalization of $46.81 billion, a price-to-earnings ratio of 28.11 and a beta of 0.73. CME Group Inc. has a one year low of $98.95 and a one year high of $138.49.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The business had revenue of $925.00 million for the quarter, compared to the consensus estimate of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The company’s revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 earnings per share. On average, equities research analysts predict that CME Group Inc. will post $4.81 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 25th. Shareholders of record on Friday, September 8th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 1.92%. The ex-dividend date of this dividend was Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 53.99%.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/12/cme-group-inc-cme-cfo-sells-342075-00-in-stock.html.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Fiduciary Trust Co. purchased a new stake in shares of CME Group in the second quarter worth about $105,000. Quadrant Capital Group LLC lifted its holdings in shares of CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after buying an additional 113 shares in the last quarter. San Francisco Sentry Investment Group CA purchased a new stake in shares of CME Group in the second quarter worth about $129,000. Whittier Trust Co. lifted its holdings in shares of CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after buying an additional 27 shares in the last quarter. Finally, People s United Financial Inc. lifted its holdings in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after buying an additional 110 shares in the last quarter. 82.64% of the stock is currently owned by institutional investors and hedge funds.

A number of analysts have recently issued reports on the stock. Barclays PLC raised their target price on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research note on Tuesday. Wells Fargo & Company raised their target price on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research note on Wednesday, October 4th. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Keefe, Bruyette & Woods restated a “hold” rating and set a $133.00 target price on shares of CME Group in a research note on Thursday, September 21st. Finally, Royal Bank Of Canada raised their target price on shares of CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. CME Group presently has a consensus rating of “Buy” and a consensus price target of $135.89.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.